Complete Story
 

04/02/2019

WPS Oncology Related LCD Updates

April 2019

April 2019 Local Coverage Determination (LCD)/Coverage Article Updates

The following is a list of the Local Coverage Determinations (LCDs) and Coverage Articles updated by WPS GHA for April 2019. Additional details about these updates are available in the full article on our website.
 
New Policies/Articles
  • MolDX: Decipher® Biopsy Prostate Cancer Classifier Assay for Men with Very Low and Low Risk Disease - Effective 05/13/2019
  • MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test - Effective 05/13/2019
  • MolDX: MDS FISH - Effective 05/13/2019
                       
Retired Policies/Articles - Effective 04/14/2019
  • MolDX: Breast Cancer Index Genetic Assay
 
Revised Policies/Articles
  • Human Granulocyte/Macrophage Colony Stimulating Factors Billing and Coding Guidelines - Effective 03/19/2019
  • MolDX: BDX-XL2 - Effective 01/01/2019
  • MolDX: Decision Dx-UM (Uveal Melanoma) - Effective 03/28/2019
  • MolDX: Myriad's BRACAnalysis CDx® Coding and Billing Guidelines - Effective 05/13/2019
 
To access Local Coverage Determinations (LCDs) and Coverage Articles from the WPS GHA website, please visit our Local Coverage Determinations (LCDs) and Coverage Articles web page. 

 

Printer-Friendly Version


Report Broken Links

Have you encountered a problem with a URL (link) on this page not working or displaying an error message? Help us fix it! 
Report Broken Link